Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.35 0.1398 +66.54%
CYTK $13.02 1.0999 +9.23%
ARRY $4.07 0.2700 +7.11%
GERN $2.08 0.0800 +4.00%
GALE $2.38 0.0850 +3.71%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TGTX $4.90 -0.2600 -5.04%
AGIO $44.08 -2.2600 -4.88%
ENMD $1.87 -0.0700 -3.61%
VRML $2.81 -0.0897 -3.09%
ZIOP $3.55 -0.1100 -3.01%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Novartis Cushing's Drug Passes Late-Stage Test

(TheStreet) Sept 22, 2010 - Novartis it will seek regulatory approval by the end of the year for a new drug to treat Cushing's disease based on positive results from a phase III study released Wednesday.
read article 

Sanofi-Aventis Says Tamaris Phase III Trial Did Not Mean Primary Endpoint

(Bloomberg) Sept 22, 2010 - Sanofi-Aventis SA said a drug that had showed promise in restoring blood vessel growth in damaged limbs was no better than a placebo in an advanced test.
read article 

Staying on Gleevec Seems to Help Gastro Cancer Patients

(Bloomberg Businessweek) Sept 22, 2010 - Continuous treatment with imatinib (Gleevec) is recommended for patients with advanced gastrointestinal cancer, a new study suggests.
read article 

GlaxoSmithKline Sues Roche Over Patents for Cancer Treatment Herceptin

(Bloomberg) Sept 21, 2010 - A U.S. unit of GlaxoSmithKline Plc, the U.K.’s largest drugmaker, sued rival Roche Holding AG and its Genentech Inc. unit over a patent used in the cancer drug Herceptin.
read article 

Teva's Biosimilar Takes Wider Aim at Roche Drug

(Reuters) Sept 22, 2010 - Israel's Teva Pharmaceutical Industries is taking wider aim at Roche's blockbuster antibody drug Rituxan by launching a second clinical trial using a copy of the drug to treat non-Hodgkin's lymphoma.
read article 

Dendreon: Assessing New Threat to Provenge

(TheStreet) Sept 22, 2010 - Dendreon may have less to worry about from a competing prostate cancer drug owned by AstraZeneca.
read article 

Drug Protects Heart in Children Receiving Common Chemotherapy

(NCI Cancer Bulletin) Sept 21, 2010 - The drug dexrazoxane, which can protect heart tissue from the oxidative damage caused by doxorubicin and other anthracycline drugs, significantly reduced the occurrence of long-term heart damage in children undergoing treatment for high-risk acute lymphoblastic leukemia (ALL).
read article 

When Ovarian Cancer Returns Years Later

(NCI Cancer Bulletin) Sept 21, 2010 - In 1995, when Susan Lowell Butler was unlucky enough to be diagnosed simultaneously with advanced ovarian and advanced breast cancer at age 52, doctors began to talk about her “tumor burden.”
read article 

Low-Cost Cervical Cancer Vaccine, Developed by UCCC Researchers, Moves to Human Trials

(Colorado Cancer Blogs/UCCC) Sept 21, 2010 - A low-cost cervical cancer vaccine developed by University of Colorado Cancer Center researchers is set to begin testing in human trials.
read article 

'Synthetic Lethality' Strategy Improves Molecularly Targeted Cancer Therapy

(Fox Chase Cancer Center) Sept 21, 2010 - Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time.
read press release 

Soy's Connections to Breast Cancer Now Questioned

(Chicago Tribune) Sept 22, 2010 - Where it was once believed too much soy in a diet could increase the risk of developing breast cancer, newer findings suggest high-soy diets can reduce the risk of breast cancer recurrence and death.
read article (free registration required) 

Is the Inability of Cancer Patients to Eat a Concern?

(CNNHealth Blog) Sept 22, 2010 - Q: I wanted to see what your experts thought about cancer/chemotherapy patients and protein malnutrition. I have read it leads to as many as 45 to 50 percent of cancer deaths. Is the inability of cancer patients to eat of major concern to cancer health care providers?
read article 

ProNAi Initiates Phase I Cancer Clinical Study of PNT2258

(ProNAi) Sept 20, 2010 - ProNAi Therapeutics, Inc., a privately held biopharmaceutical company, announced today dosing of its first patient in an open-label, single- arm, Phase I dose-escalation study of PNT2258 in patients with advanced solid tumors for which no standard therapy exists.
download PDF 

FDA Staff Questions Hologic's 3D Mammogram System

(Reuters) Sept 22, 2010 - Hologic Inc's three-dimensional digital mammogram technology appears to help doctors screen for breast cancer but issues remain over some of the company's data, U.S. health reviewers said in documents released on Wednesday.
read article 

Gen-Probe Seeks FDA Approval of Prostate Cancer Test

(San Diego Union-Tribune) Sept 21, 2010 - San Diego medical diagnostics maker Gen-Probe said it submitted a premarket approval application to the Food and Drug Administration for its Progensa PCA3 test, which screens urine samples for a gene tied to prostate cancer.
read article 

A New Way To Find Cancer Drugs

(Forbes Treatments Blog) Sept 21, 2010 - Drug companies testing drugs for cancer and other diseases have long gone after one bad protein at a time. Merrimack Pharmaceuticals chief executive Robert Mulroy says this approach is fundamentally flawed.
read article 

Ask Your Representative to Sign Letter Opposing Cuts to Cancer Care

(ASCO in Action) Sept 21, 2010 - Representatives Steve Israel (D-NY), Debbie Wasserman Schultz (D—FL), Artur Davis (D-AL), Edolphus Towns (D-NY), and Betty Sutton (D-OH) have circulated a “Dear Colleague” letter asking their colleagues in the House to sign onto their letter to the Secretary of Health and Human Services (HHS), Kathleen Sebelius.
read article 

U.S. Seeks to Join Pfizer Whistleblower Lawsuit

(Bloomberg) Sept 21, 2010 - The U.S. Justice Department is seeking to join a whistleblower lawsuit over Pfizer Inc.’s organ transplant drug Rapamune alleging the medicine was illegally marketed, according to court papers.
read article 

Need for Speed: How to Get Faster Drug Reviews in Europe

(WSJ Health Blog) Sept 21, 2010 - The drive to encourage drug development in rare and neglected diseases is picking up steam.
read article (paid subscription required) 

AUA Champions New Prostate Legislation Introduced to Senate

(AUA) Sept 17, 2010 - AUA urges Congress to establish inter-agency task force to align current federal efforts in prostate cancer research, awareness and healthcare delivery.
read press release 

Analysis: Global Drug Firms Take Aim at Made-for-China Healthcare

(Reuters) Sept 21, 2010 - Diseases such as cancers of the liver, stomach, head and neck have previously fallen under the radar of firms like Roche Holding AG, Merck and Novartis, because they are not widespread in the United States, the world's No. 1 pharmaceutical market, or in the west.
read article 

German Firm Gets $70 Mln for Cancer Vaccine Study

(Reuters) Sept 21, 2010 - German biotech firm Immatics has raised 53.8 million euros ($70.5 million) to help fund late-stage clinical testing of an experimental vaccine against kidney cancer, it said on Tuesday.
read article 

Less Invasive Surgery OK for Breast Cancer

(Washington Post) Sept 20, 2010 - Some breast cancer patients may do just as well with a less invasive surgery to remove selected lymph nodes rather than the aggressive operation normally used to remove them all, a new study says.
read article (free registration required) 

Who Gets Genetic Testing for Cancer?

(WSJ Health Blog) Sept 20, 2010 - Aetna is examining data from 13,000 of its members to figure out if patients who should be getting breast-and-ovarian cancer screening tests are in fact being offered them.
read article (paid subscription required) 

Dendreon Inks Supply Deal with Glaxo on Cancer Vaccine

(Reuters) Sept 21, 2010 - Dendreon Corp said it signed a development and supply agreement with GlaxoSmithKline on its novel prostate cancer vaccine, alleviating investors' concerns about the biotech firm's ability to provide an adequate supply of the vaccine.
read article